← Leaderboards
Daniel Y Wu
University Of Washington
$1,275,506
Attributed
$1,275,506
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $243K · FY2006–10$250K$187.5K$125K$62.5K$0
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$1,275,506 · 2
By mechanism
R01$1,186,806 · 1
K08$88,700 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Washington
Same institution · by research overlap
- Michael Lagunoff$11,646,302
- Long Fu Xi$3,769,214
- Nancy B. Kiviat$21,349,193
- Ryan M Teague$3,617,288
- Charles D Laird$2,119,575
Others in their field
Top investigators on “Cyclins”
- Piotr Sicinski · Dana-Farber Cancer Inst$42,699,610
- J. Alan Diehl · University Of Nebraska Medical Center$21,437,568
- Richard G Pestell · Yeshiva University$16,269,311
- Steven I Reed · Scripps Research Institute$16,177,190
- Bruce E Clurman · Fred Hutchinson Cancer Research Center$15,606,607
- David Owen Morgan · University Of California San Francisco$15,595,703
Research focus
CyclinsDna DamageCollaborationsCyclin-Dependent KinasesBaseDifferentiation InducerCancer CellClinically RelevantCyclin B1AccountingBypassCdc2 Protein KinaseCamptothecinCell AgingCell CycleCell Cycle ArrestCancer PatientBinding (Molecular Function)CellsCancer TherapyCessation Of LifeCharacteristicsChemotherapyDna Methylation
Grant awards (6)
Pathways of Therapy-induced Senescence in Cancer$235,952
R01 · FY2010 · CA · contact PI
Pathways of Therapy-induced Senescence in Cancer$235,952
R01 · FY2009 · CA · contact PI
Pathways of Therapy-induced Senescence in Cancer$235,952
R01 · FY2008 · CA · contact PI
Pathways of Therapy-induced Senescence in Cancer$235,952
R01 · FY2007 · CA · contact PI
Pathways of Therapy-induced Senescence in Cancer$242,998
R01 · FY2006 · CA · contact PI
INIL AND EBV MEDIATED LYMPHOMAGENESIS$88,700
K08 · FY2000 · CA